Löser C, Brauer C, Aygen S, Hennemann O, Fölsch U R
Ist Medical Dept., Christian-Albrechts University of Kiel, Germany.
Scand J Gastroenterol. 1998 Mar;33(3):327-34. doi: 10.1080/00365529850170946.
Breath tests using stable isotopes of carbon or hydrogen are increasingly becoming established for the evaluation of various gastrointestinal functions, including measurement of exocrine pancreatic insufficiency. We wanted to evaluate the clinical relevance of the non-invasive, non-radioactive 13C-mixed triglyceride breath test in comparison with the secretin-caerulein test as the 'gold standard' of pancreatic function testing and with faecal chymotrypsin and elastase 1 in patients with mild and severe exocrine pancreatic insufficiency.
The secretin-caerulein test, faecal fat analysis, 13C-mixed triglyceride breath test, faecal elastase 1, and chymotrypsin and various morphologic investigations were done in 26 patients with mild (n = 13) or severe (n = 13) exocrine pancreatic insufficiency and 25 patients with gastrointestinal diseases of non-pancreatic origin. Twenty-seven healthy volunteers served as normal controls. After a 12-h fast 200 mg mixed triglyceride (1,3-distearyl,2(carboxyl-13C)octanoyl glycerol) were orally administered with a test meal, and breath samples were taken before and at 30-min intervals for 5 h thereafter, and the increase in 13C/12C isotopic ratio in breath was analysed by mass spectrometry. Various modifications of the test procedure were investigated.
Specificity for impaired pancreatic function was higher for faecal elastase (90%) and equal for faecal chymotrypsin (82%) as compared with the various variables of the 13C-mixed triglyceride breath test (69-85%). The sensitivity of the 13C-mixed triglyceride breath test for total and separately for mild and severe exocrine pancreatic insufficiency was higher (total, 69-81%) than that of faecal chymotrypsin (total, 56%) but lower than faecal elastase (total, 92%).
The 13C-mixed triglyceride breath test very sensitively reflects severe exocrine pancreatic insufficiency (steatorrhoea) but has limited sensitivity for the detection of mild cases. With regard to the higher sensitivity and specificity, the higher practicability, and the much lower cost, determination of faecal elastase 1 concentrations is superior to the 13C-mixed triglyceride breath test and therefore remains the most reliable indirect pancreatic function test available today.
使用碳或氢的稳定同位素进行呼气试验越来越多地用于评估各种胃肠功能,包括外分泌性胰腺功能不全的检测。我们希望通过与作为胰腺功能检测“金标准”的促胰液素-雨蛙素试验以及与轻、重度外分泌性胰腺功能不全患者的粪便糜蛋白酶和弹性蛋白酶1进行比较,来评估非侵入性、无放射性的13C-混合甘油三酯呼气试验的临床相关性。
对26例轻度(n = 13)或重度(n = 13)外分泌性胰腺功能不全患者以及25例非胰腺源性胃肠疾病患者进行了促胰液素-雨蛙素试验、粪便脂肪分析、13C-混合甘油三酯呼气试验、粪便弹性蛋白酶1和糜蛋白酶检测以及各种形态学检查。27名健康志愿者作为正常对照。禁食12小时后,将200mg混合甘油三酯(1,3-二硬脂酰基,2-(羧基-13C)辛酰基甘油)与试验餐一起口服,之后在服用前及此后5小时内每隔30分钟采集呼气样本,通过质谱分析呼气中13C/12C同位素比值的增加情况。对试验程序的各种修改进行了研究。
与13C-混合甘油三酯呼气试验的各种变量(69 - 85%)相比,粪便弹性蛋白酶对胰腺功能受损诊断的特异性更高(90%),粪便糜蛋白酶的特异性与之相当(82%)。13C-混合甘油三酯呼气试验对总的以及分别对轻度和重度外分泌性胰腺功能不全的敏感性更高(总的,69 - 81%),高于粪便糜蛋白酶(总的,56%),但低于粪便弹性蛋白酶(总的,92%)。
13C-混合甘油三酯呼气试验能非常敏感地反映重度外分泌性胰腺功能不全(脂肪泻),但对轻度病例的检测敏感性有限。就更高的敏感性和特异性、更高的实用性以及更低的成本而言,粪便弹性蛋白酶1浓度的测定优于13C-混合甘油三酯呼气试验,因此仍然是目前最可靠的间接胰腺功能检测方法。